We previously demonstrated that inhibition of NMD by ASO-mediated reduction of a branch-specific NMD factor, Upf3b [55,56], significantly stabilized hFIX mRNA harboring an early nonsense mutation (R29X) and significantly improved the efficacy of read-through therapy in this mouse hemophilia model [57]. This evidence concerns the gene UPF3B and hemophilia.